| Trial ID: | L0414 |
| Source ID: | NCT04537780
|
| Associated Drug: |
Montelukast
|
| Title: |
Clinical Study Evaluating the Efficacy and Safety of Montelukast in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
|
| Acronym: |
--
|
| Status: |
Not recruiting
|
| Study Results: |
No Results Available
|
| Results: |
--
|
| Conditions: |
Non Alcoholic Steatohepatitis
|
| Interventions: |
Other: Placebo;Drug: Montelukast
|
| Outcome Measures: |
serum 8-Hydroxy2-deoxyguanisine (8-OHdG);TNF-a.;Alanine aminotransferase (ALT).;Aspartate aminotransferase (AST);?-glutamyltranspeptidase(GGT)nan
|
| Sponsor/Collaborators: |
Tanta University
|
| Gender: |
All
|
| Age: |
20 Years70 Years
|
| Phases: |
Phase 4
|
| Enrollment: |
44
|
| Study Type: |
Interventional
|
| Study Designs: |
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Double (Participant, Investigator).
|
| Start Date: |
30/08/2020
|
| Completion Date: |
--
|
| Results First Posted: |
--
|
| Last Update Posted: |
12 December 2020
|
| Locations: |
Egypt
|
| URL: |
https://clinicaltrials.gov/show/NCT04537780
|
